Description
Survodutide is an investigational dual-acting peptide designed to support metabolic health and body composition by targeting both glucagon and GLP-1 receptor pathways. Through this combined mechanism, Survodutide may help regulate appetite, improve energy utilization, and support fat reduction while maintaining metabolic balance.
By influencing hunger signaling and energy expenditure simultaneously, Survodutide has shown promising potential in obesity and metabolic research. Early studies suggest it may assist with appetite control, weight management, and improved metabolic flexibility while supporting healthier glucose regulation.







There are no reviews yet.